nimodipine has been researched along with Psychotic Disorders in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent data indicate that patients with vascular dementia (VaD) show a cholinergic deficit." | 2.71 | Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study. ( Antonello, RM; Bava, A; Cazzato, G; Griggio, S; Moretti, R; Torre, P; Ukmar, M, 2004) |
| "Pre-treatment with verapamil (10 and 20 mg/kg, i." | 1.31 | Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey. ( Dubey, MP; Kalsotra, A; Kumar, R; Nath, C; Palit, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moretti, R | 1 |
| Torre, P | 1 |
| Antonello, RM | 1 |
| Cazzato, G | 1 |
| Griggio, S | 1 |
| Ukmar, M | 1 |
| Bava, A | 1 |
| Palit, G | 1 |
| Kalsotra, A | 1 |
| Kumar, R | 1 |
| Nath, C | 1 |
| Dubey, MP | 1 |
1 trial available for nimodipine and Psychotic Disorders
| Article | Year |
|---|---|
Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
Topics: Aged; Aged, 80 and over; Aspirin; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Dement | 2004 |
1 other study available for nimodipine and Psychotic Disorders
| Article | Year |
|---|---|
Behavioural and anti-psychotic effects of Ca2+ channel blockers in rhesus monkey.
Topics: Amphetamine; Animals; Behavior, Animal; Calcium Channel Blockers; Central Nervous System Stimulants; | 2001 |